BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24774264)

  • 1. Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis.
    Farré N; Gómez M; Molina L; Cladellas M; Blé M; Roqueta C; Ascoeta MS; Comin-Colet J; Vila J; Bruguera J
    Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):52-7. PubMed ID: 24774264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of NT-proBNP in identifying impaired coronary flow reserve in asymptomatic moderate or severe aortic stenosis.
    Banovic M; Vujisic-Tesic B; Bojic S; Mladenovic A; Ignjatovic S; Petrovic M; Trifunovic D; Nedeljkovic I; Popovic D; Callahan M; Seferovic P
    Biomark Med; 2013 Apr; 7(2):221-7. PubMed ID: 23547817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.
    Weber M; Hausen M; Arnold R; Moellmann H; Nef H; Elsaesser A; Mitrovic V; Hamm C
    Int J Cardiol; 2008 Jul; 127(3):321-7. PubMed ID: 18055041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis.
    Weber M; Hausen M; Arnold R; Nef H; Moellman H; Berkowitsch A; Elsaesser A; Brandt R; Mitrovic V; Hamm C
    Heart; 2006 Nov; 92(11):1639-44. PubMed ID: 16740919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of tissue Doppler imaging and natriuretic peptides as prognostic marker in asymptomatic aortic stenosis.
    Gomez Perez M; Ble M; Cladellas M; Molina L; Vila J; Mas-Stachurska A; Higueras-Ortega L; Marti-Almor J
    Int J Cardiol; 2017 Feb; 228():890-894. PubMed ID: 27894060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
    Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
    Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
    Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
    J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis.
    Weber M; Arnold R; Rau M; Brandt R; Berkovitsch A; Mitrovic V; Hamm C
    Am J Cardiol; 2004 Sep; 94(6):740-5. PubMed ID: 15374777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants and prognostic value of B-type natriuretic peptide in patients with aortic valve stenosis.
    Nguyen V; Cimadevilla C; Arangalage D; Dehoux M; Codogno I; Duval X; Tubiana S; Vahanian A; Messika-Zeitoun D
    Int J Cardiol; 2017 Mar; 230():371-377. PubMed ID: 28062138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study.
    Cimadevilla C; Cueff C; Hekimian G; Dehoux M; Lepage L; Iung B; Duval X; Huart V; Tubach F; Vahanian A; Messika-Zeitoun D
    Heart; 2013 Apr; 99(7):461-7. PubMed ID: 23349346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of N-Terminal Pro-form B-Type Natriuretic Peptide in Patients With Moderate Aortic Stenosis.
    Ito S; Miranda WR; Jaffe AS; Oh JK
    Am J Cardiol; 2020 May; 125(10):1566-1570. PubMed ID: 32204871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease.
    Weber M; Arnold R; Rau M; Elsaesser A; Brandt R; Mitrovic V; Hamm C
    Eur Heart J; 2005 May; 26(10):1023-30. PubMed ID: 15781428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
    Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of NT-proBNP concentrations during exercise in asymptomatic patients with severe high-gradient aortic stenosis.
    Dobrowolski P; Lech A; Klisiewicz A; Hoffman P
    Pol Arch Med Wewn; 2016 Aug; 126(9):635-641. PubMed ID: 27515778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between prosthesis-patient mismatch and pro-brain natriuretic peptides after aortic valve replacement.
    Melina G; Angeloni E; Benedetto U; Refice S; Miceli A; Miele C; Ciavarella GM; Sinatra R
    J Heart Valve Dis; 2010 Mar; 19(2):171-6. PubMed ID: 20369499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NT-proBNP changes, oxidative stress, and energy status of hypertrophic myocardium following ischemia/reperfusion injury.
    Scolletta S; Carlucci F; Biagioli B; Marchetti L; Maccherini M; Carlucci G; Rosi F; Salvi M; Tabucchi A
    Biomed Pharmacother; 2007; 61(2-3):160-6. PubMed ID: 17350221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.